Expected earnings - Metagenomi Therapeutics Inc Com
Source: US Earnings Reports
Metagenomi Therapeutics Inc Com (MGX) is expected to report $-0.58 for Q4 2025
Metagenomi Inc.
NASDAQ: MGX
MGX Trading
-8.09% G/L:
$1.489 Last:
326,987 Volume:
$1.55 Open:
MGX Latest News
March 05, 2026 04:05:00 pm
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
February 23, 2026 04:05:00 pm
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
MGX Stock Data
$58,948,399
30,863,429
9%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
